Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBI-R2: Hydroxychloroquine with Dabrafenib and Trametinib in Advanced Melanoma
NCT03754179Phase 2Unknown
- Sponsor
- UZ Brussel
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in melanoma, sponsored by UZ Brussel. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03754179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754179.